http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#Head
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#assertion
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#provenance
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#pubinfo
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#assertion
http://purl.obolibrary.org/obo/DOID_1724
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_1724
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01129
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#association
http://www.w3.org/2000/01/rdf-schema#label
1 1 healing of erosive or ulcerative gerd in adults rabeprazole sodium delayed release tablets are indicated for short term 4 to 8 weeks treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease gerd for those patients who have not healed after 8 weeks of treatment an additional 8 week course of rabeprazole sodium delayed release tablets may be considered 1 2 maintenance of healing of erosive or ulcerative gerd in adults rabeprazole sodium delayed release tablets are indicated for maintaining healing and reduction in relapse rates of heartburn symptoms in patients with erosive or ulcerative gastroesophageal reflux disease gerd maintenance controlled studies do not extend beyond 12 months 1 3 treatment of symptomatic gerd in adults rabeprazole sodium delayed release tablets are indicated for the treatment of daytime and nighttime heartburn and other symptoms associated with gerd in adults for up to 4 weeks 1 4 healing of duodenal ulcers in adults rabeprazole sodium delayed release tablets are indicated for short term up to four weeks treatment in the healing and symptomatic relief of duodenal ulcers most patients heal within four weeks 1 5 helicobacter pylori eradication to reduce the risk of duodenal ulcer recurrence in adults rabeprazole sodium delayed release tablets in combination with amoxicillin and clarithromycin as a three drug regimen are indicated for the treatment of patients with h pylori infection and duodenal ulcer disease active or history within the past 5 years to eradicate h pylori eradication of h pylori has been shown to reduce the risk of duodenal ulcer recurrence see clinical studies 14 5 and dosage and administration 2 5 in patients who fail therapy susceptibility testing should be done if resistance to clarithromycin is demonstrated or susceptibility testing is not possible alternative antimicrobial therapy should be instituted see clinical pharmacology 12 2 and the clarithromycin package insert clinical pharmacology 12 2 1 6 treatment of pathological hypersecretory conditions including zollinger ellison syndrome in adults rabeprazole sodium delayed release tablets are indicated for the long term treatment of pathological hypersecretory conditions including zollinger ellison syndrome 1 7 short term treatment of symptomatic gerd in adolescent patients 12 years of age and older rabeprazole sodium delayed release tablets are indicated for the treatment of symptomatic gerd in adolescents 12 years of age and above for up to 8 weeks
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB01129
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#provenance
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#pubinfo
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#sig
http://purl.org/nanopub/x/hasSignature
LHRI4PATTQQ2rHIPSmVhjK7w+UzEcD476dECN8IXU2ROb2jg+JAsqqYjf2QA+XYaRBHj/amGeS4err2UYQrp/Eu0mgJVesUyKH5voU7AlkD6QUXtQJJ+xf4BihUNN/0e77fuXdMjcsbWlT/QBcYgnHtSXVroSJqvNIj0CIWYhrI=
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew
http://purl.org/dc/terms/created
2021-06-14T08:31:29.099+02:00
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAdasV-ISM_2N8Wp953PcAAbPPCIU6KwEfZ6Sg-Fkgvew
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs